The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
The Type I IFN Response to Infection with Mycobacterium tuberculosis Requires ESX-1-Mediated Secretion and Contributes to Pathogenesis
Open accessAbstract
The ESX-1 secretion system is a major determinant of Mycobacterium tuberculosis virulence, although the pathogenic mechanisms resulting from ESX-1-mediated transport remain unclear. By global transcriptional profiling of tissues from mice infected with either wild-type or ESX-1 mutant bacilli, we found that host genes controlled by ESX-1 in vivo are predominantly IFN regulated. ESX-1-mediated secretion is required for the production of host type I IFNs during infection in vivo and in macrophages in vitro. The macrophage signaling pathway leading to the production of type I IFN required the host kinase TANK-binding kinase 1 and occurs independently of TLR signaling. Importantly, the induction of type I IFNs during M. tuberculosis infection is a pathogenic mechanism as mice lacking the type I IFNR were more restrictive for bacterial growth in the spleen than wild-type mice, although growth in the lung was unaffected. We propose that the ESX-1 secretion system secretes effectors into the cytosol of infected macrophages, thereby triggering the type I IFN response for the manipulation of host immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Exploring the Metabolic and Genetic Control of Gene Expression on a Genomic Scale
DeRisi, J. L., Iyer, V. R., & Brown, P. O. (1997) · Science · doi:10.1126/science.278.5338.680 · Cited by 4,456
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
IKKε and TBK1 are essential components of the IRF3 signaling pathway
Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S.-M., & Maniatis, T. (2003) · Nature Immunology · doi:10.1038/ni921 · Cited by 2,676
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., & Bloom, B. R. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2249 · Cited by 2,465
Triggering the Interferon Antiviral Response Through an IKK-Related Pathway
Sharma, S., tenOever, B. R., Grandvaux, N., Zhou, G.-P., Lin, R., & Hiscott, J. (2003) · Science · doi:10.1126/science.1081315 · Cited by 1,661
Yamamoto, M., Sato, S., Mori, K., Hoshino, K., Takeuchi, O., Takeda, K., & Akira, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.6668 · Cited by 1,227
Kawai, T., Takeuchi, O., Fujita, T., Inoue, J.-I., Mühlradt, P. F., Sato, S., Hoshino, K., & Akira, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5887 · Cited by 1,095
NODs: intracellular proteins involved in inflammation and apoptosis
Inohara, N., & Nuñez, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1086 · Cited by 1,064
RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems
Kobayashi, K., Inohara, N., Hernandez, L. D., Galán, J. E., Núñez, G., Janeway, C. A., Medzhitov, R., & Flavell, R. A. (2002) · Nature · doi:10.1038/416194a · Cited by 893
Human Toll-Like Receptors Mediate Cellular Activation by Mycobacterium tuberculosis
Means, T. K., Wang, S., Lien, E., Yoshimura, A., Golenbock, D. T., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3920 · Cited by 804
Hsu, T., Hingley-Wilson, S. M., Chen, B., Chen, M., Dai, A. Z., Morin, P. M., Marks, C. B., Padiyar, J., Goulding, C., Gingery, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1635213100 · Cited by 731
Manca, C., Tsenova, L., Bergtold, A., Freeman, S., Tovey, M., Musser, J. M., Barry, C. E., Freedman, V. H., & Kaplan, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091096998 · Cited by 595
Pomerantz, J. L. (1999) · The EMBO Journal · doi:10.1093/emboj/18.23.6694 · Cited by 592
Stanley, S. A., Raghavan, S., Hwang, W. W., & Cox, J. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235593100 · Cited by 570
Self-citationHuman macrophage activation programs induced by bacterial pathogens
Nau, G. J., Richmond, J. F. L., Schlesinger, A., Jennings, E. G., Lander, E. S., & Young, R. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022649799 · Cited by 568
Guinn, K. M., Hickey, M. J., Mathur, S. K., Zakel, K. L., Grotzke, J. E., Lewinsohn, D. M., Smith, S., & Sherman, D. R. (2004) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03844.x · Cited by 510
Type I Interferon Production Enhances Susceptibility to Listeria monocytogenes Infection
O'Connell, R. M., Saha, S. K., Vaidya, S. A., Bruhn, K. W., Miranda, G. A., Zarnegar, B., Perry, A. K., Nguyen, B. O., Lane, T. F., Taniguchi, T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040712 · Cited by 489
Mice Lacking the Type I Interferon Receptor Are Resistant to Listeria monocytogenes
Auerbuch, V., Brockstedt, D. G., Meyer-Morse, N., O'Riordan, M., & Portnoy, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040976 · Cited by 450
Giacomini, E., Iona, E., Ferroni, L., Miettinen, M., Fattorini, L., Orefici, G., Julkunen, I., & Coccia, E. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7033 · Cited by 433
Means, T. K., Lien, E., Yoshimura, A., Wang, S., Golenbock, D. T., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6748 · Cited by 431
Perry, A. K., Chow, E. K., Goodnough, J. B., Yeh, W.-C., & Cheng, G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040528 · Cited by 399
Mutually dependent secretion of proteins required for mycobacterial virulence.
Fortune, S. M., Jaeger, A., Sarracino, D. A., Chase, M. R., Sassetti, C. M., Sherman, D. R., Bloom, B. R., & Rubin, E. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504922102 · Cited by 396
Type I Interferon Sensitizes Lymphocytes to Apoptosis and Reduces Resistance to Listeria Infection
Carrero, J. A., Calderon, B., & Unanue, E. R. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040769 · Cited by 390
NOD2 and Toll-Like Receptors Are Nonredundant Recognition Systems of Mycobacterium tuberculosis
Ferwerda, G., Girardin, S. E., Kullberg, B.-J., Le Bourhis, L., de Jong, D. J., Langenberg, D. M. L., van Crevel, R., Adema, G. J., Ottenhoff, T. H. M., Van der Meer, J. W. M., et al. (2005) · PLoS Pathogens · doi:10.1371/journal.ppat.0010034 · Cited by 365
The host type I interferon response to viral and bacterial infections
PERRY, A. K., CHEN, G., ZHENG, D., TANG, H., & CHENG, G. (2005) · Cell Research · doi:10.1038/sj.cr.7290309 · Cited by 360
Hemmi, H., Kaisho, T., Takeda, K., & Akira, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3059 · Cited by 340
Renshaw, P. S., Panagiotidou, P., Whelan, A., Gordon, S. V., Hewinson, R. G., Williamson, R. A., & Carr, M. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201625200 · Cited by 340
Structure and function of the complex formed by the tuberculosis virulence factors CFP‐10 and ESAT‐6
Renshaw, P. S., Lightbody, K. L., Veverka, V., Muskett, F. W., Kelly, G., Frenkiel, T. A., Gordon, S. V., Hewinson, R. G., Burke, B., Norman, J., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600732 · Cited by 334
Tuberculous Granuloma Formation Is Enhanced by a Mycobacterium Virulence Determinant
Volkman, H. E., Clay, H., Beery, D., Chang, J. C. W., Sherman, D. R., & Ramakrishnan, L. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020367 · Cited by 315
Ting, L. M., Kim, A. C., Cattamanchi, A., & Ernst, J. D. (1999) · PubMed · Cited by 315
Innate recognition of bacteria by a macrophage cytosolic surveillance pathway
O'Riordan, M., Yi, C. H., Gonzales, R., Lee, K.-D., & Portnoy, D. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202476699 · Cited by 282
Ting, L.-M., Kim, A. C., Cattamanchi, A., & Ernst, J. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3898 · Cited by 257
Lee, J., Remold, H. G., Ieong, M. H., & Kornfeld, H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4267 · Cited by 238
Protein secretion and the pathogenesis of bacterial infections
Lee, V. T., & Schneewind, O. (2001) · Genes & Development · doi:10.1101/gad.896801 · Cited by 220
Fortune, S. M., Solache, A., Jaeger, A., Hill, P. J., Belisle, J. T., Bloom, B. R., Rubin, E. J., & Ernst, J. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6272 · Cited by 206
The ESAT-6/CFP-10 secretion system of Mycobacterium marinum modulates phagosome maturation
Tan, T., Lee, W. L., Alexander, D. C., Grinstein, S., & Liu, J. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00721.x · Cited by 173
Cooper, A. M., Pearl, J. E., Brooks, J. V., Ehlers, S., & Orme, I. M. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.6879-6882.2000 · Cited by 135
Control of Mycobacterium tuberculosis through mammalian Toll-like receptors
Stenger, S., & Modlin, R. L. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00355-2 · Cited by 132
Shi, S., Blumenthal, A., Hickey, C. M., Gandotra, S., Levy, D. E., & Ehrt, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.3318 · Cited by 119
Nagai, T., Devergne, O., Mueller, T., Perkins, D. L., van Seventer, J. M., & van Seventer, G. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5233 · Cited by 110
Weiden, M. D., Tanaka, N., Qiao, Y., Zhao, B. Y., Honda, Y., Nakata, K., Canova, A., Levy, D. E., Rom, W. N., & Pine, R. I. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.2028 · Cited by 107
O’Connell, R. M., Vaidya, S. A., Perry, A. K., Saha, S. K., Dempsey, P. W., & Cheng, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1602 · Cited by 87
Bouchonnet, F., Boéchat, N., Bonay, M., & Hance, A. J. (2002) · Infection and Immunity · doi:10.1128/iai.70.6.3020-3025.2002 · Cited by 73
Lewinsohn, D. M., Grotzke, J. E., Heinzel, A. S., Zhu, L., Ovendale, P. J., Johnson, M., & Alderson, M. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.437 · Cited by 67
Evasive Maneuvers by Secreted Bacterial Proteins to Avoid Innate Immune Responses
Coombes, B. K., Valdez, Y., & Finlay, B. B. (2004) · Current Biology · doi:10.1016/j.cub.2004.09.043 · Cited by 61
Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice
Taki, S. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00023-0 · Cited by 53
Inhibition of Response to Alpha Interferon byMycobacterium tuberculosis
Prabhakar, S., Qiao, Y., Hoshino, Y., Weiden, M. D., Canova, A., Giacomini, E., Coccia, E. M., & Pine, R. I. (2003) · Infection and Immunity · doi:10.1128/iai.71.5.2487-2497.2003 · Cited by 36
Comparison of gene coverage of mouse oligonucleotide microarray platforms
Verdugo, R. A., & Medrano, J. F. F. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-58 · Cited by 27
Activation of Toll-like Receptors by Microbial Lipoproteins
Modlin, R. L. (2001) · Scandinavian Journal of Infectious Diseases · doi:10.1080/003655401750065454 · Cited by 16
Cited by
Type I interferons in infectious disease
McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3787 · Cited by 2,780
The Immune Response in Tuberculosis
O'Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095939 · Cited by 1,342
Pai, M., Behr, M. A., Dowdy, D., Dheda, K., Divangahi, M., Boehme, C. C., Ginsberg, A., Swaminathan, S., Spigelman, M., Getahun, H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.76 · Cited by 1,270
Immunomodulatory functions of type I interferons
González-Navajas, J. M., Lee, J., David, M., & Raz, E. (2012) · Nature Reviews Immunology · doi:10.1038/nri3133 · Cited by 1,011
Ablasser, A., Bauernfeind, F., Hartmann, G., Latz, E., Fitzgerald, K. A., & Hornung, V. (2009) · Nature Immunology · doi:10.1038/ni.1779 · Cited by 893
Metadata
- Authors
- Stanley, S. A., Johndrow, J. E., Manzanillo, P., & Cox, J. S.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-03-01
- Volume
- 178
- Issue
- 5
- Pages
- 3143-3152
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1940294549
- Cited by
- 432
- References
- 50
- FWCI
- 10.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.